Bluelinea SA Market Cap ($1.29 Million)
Market Cap & Net Worth: Bluelinea SA (ALBLU)
Bluelinea SA market cap. Bluelinea SA (PA:ALBLU) has a market capitalization of $1.29 Million (€1.10 Million) as of November 8, 2026. Listed on the PA stock exchange, this France-based company holds position #30473 globally and #563 in its home market, demonstrating a -25.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bluelinea SA's stock price €0.06 by its total outstanding shares 18327137 (18.33 Million). Also see ALBLU cash flow metrics for how efficiently the company converts equity into cash flow.
Bluelinea SA Market Cap History (2015–2026)
Bluelinea SA market cap history from 2015 to 2026. Data shows change from $112.37 Million to $1.29 Million (-33.30% CAGR). Check Bluelinea SA (ALBLU) stock price for real-time trading data and today's change.
Bluelinea SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bluelinea SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Bluelinea SA (ALBLU) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.27x
Bluelinea SA's market cap is 2.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $112.37 Million | $7.22K | -$1.15K | 15563.33x | N/A |
| 2016 | $106.94 Million | $6.50K | -$3.31K | 16440.61x | N/A |
| 2017 | $108.60 Million | $6.61K | -$2.99K | 16425.94x | N/A |
| 2018 | $69.38 Million | $6.16 Million | -$2.74 Million | 11.26x | N/A |
| 2019 | $75.41 Million | $6.31 Million | -$2.79 Million | 11.96x | N/A |
| 2020 | $76.62 Million | $6.83 Million | -$2.70 Million | 11.23x | N/A |
| 2021 | $44.34 Million | $7.52 Million | -$3.30 Million | 5.89x | N/A |
| 2022 | $31.71 Million | $10.41 Million | -$1.54 Million | 3.05x | N/A |
| 2023 | $27.85 Million | $9.88 Million | -$1.62 Million | 2.82x | N/A |
| 2024 | $21.43 Million | $9.45 Million | -$1.27 Million | 2.27x | N/A |
Competitor Companies of ALBLU by Market Capitalization
Companies near Bluelinea SA in the global market cap rankings as of November 8, 2026. Also see Bluelinea SA (ALBLU) total assets for a full breakdown of the balance sheet.
Key companies related to Bluelinea SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Bluelinea SA (2015–2026)
Market capitalization of Bluelinea SA from 2015 to today. Between 2015 and today, Bluelinea SA's market cap moved from $112.37 Million to $ 1.29 Million, with a yearly change of -33.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.29 Million | -87.76% |
| 2025 | €10.50 Million | -51.00% |
| 2024 | €21.43 Million | -23.08% |
| 2023 | €27.85 Million | -12.16% |
| 2022 | €31.71 Million | -28.49% |
| 2021 | €44.34 Million | -42.13% |
| 2020 | €76.62 Million | +1.60% |
| 2019 | €75.41 Million | +8.69% |
| 2018 | €69.38 Million | -36.11% |
| 2017 | €108.60 Million | +1.55% |
| 2016 | €106.94 Million | -4.83% |
| 2015 | €112.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Bluelinea SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.29 Million USD |
| MoneyControl | $1.29 Million USD |
| MarketWatch | $1.29 Million USD |
| marketcap.company | $1.29 Million USD |
| Reuters | $1.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bluelinea SA
Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting caregivers and staff in shared accommodation between seniors, serviced residences, EHPADs, specializ… Read more